Modulation of Alzheimer's beta-amyloid neurotoxicity by site-directed single-chain antibody. (Q53234947)

12 May 2018

title

Modulation of Alzheimer's beta-amyloid neurotoxicity by site-directed single-chain antibody. (English)

1 reference

12 May 2018

1 reference

1 reference

1 reference

3

1 reference

12 May 2018

author name string

Frenkel D

series ordinal

1

1 reference

12 May 2018

Solomon B

series ordinal

2

1 reference

12 May 2018

publication date

1 July 2000

1 reference

12 May 2018

Journal of Neuroimmunology

published in

1 reference

12 May 2018

volume

106

1 reference

12 May 2018

issue

1-2

1 reference

12 May 2018

page(s)

23-31

1 reference

12 May 2018

Role of the beta-amyloid precursor protein in Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Matrix-Assisted Refolding of Single-Chain Fv– Cellulose Binding Domain Fusion Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Phage display of a cellulose binding domain from Clostridium thermocellum and its application as a tool for antibody engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Conformations of immunoglobulin hypervariable regions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Aggregation and disaggregation of senile plaques in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

High affinity binding of monoclonal antibodies to the sequential epitope EFRH of beta-amyloid peptide is essential for modulation of fibrillar aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

N-terminal EFRH sequence of Alzheimer's beta-amyloid peptide represents the epitope of its anti-aggregating antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Designing and optimizing library selection strategies for generating high-affinity antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Antibody phage display technology and its applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Sequence effects on the conformational properties of the amyloid beta (1-28) peptide: testing a proposed mechanism for the alpha-->beta transition.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Targeting Bacteriophage to Mammalian Cell Surface Receptors for Gene Delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Phage antibodies: filamentous phage displaying antibody variable domains

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Intracellular antibodies: development and therapeutic potential.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Intracellular antibodies (intrabodies) for gene therapy of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

The functional expression of antibody Fv fragments in Escherichia coli: improved vectors and a generally applicable purification technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

An improved MTT assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Use of T7 RNA polymerase to direct expression of cloned genes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Solution structure of residues 1-28 of the amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Alzheimer's disease--from cause to cure?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Making antibodies by phage display technology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900232-5

7 January 2021

10.1016/S0165-5728(99)00232-5

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

10814779

1 reference

12 May 2018